Search Orphan Drug Designations and Approvals
-
Generic Name: | human laminin-111 |
---|---|
Date Designated: | 09/23/2011 |
Orphan Designation: | Treatment of merosin (laminin-alpha2) deficient congential muscular dystrophy type 1A. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Prothelia, Inc. 30 Haven Street Milford, Massachusetts 01757 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-